Several studies have shown that the application of ET-1 causes a rapid and significant decrease in CBF [49,50,51] that leads to ischemic lesion followed by gradual reperfusion [52,53], which closely resembles the CBF reduction and reperfusion that occurs in clinical stroke [53]. The gene discussed is EDN1; the disease is stroke disorder.